Paul Ehrlich as a commercial scientist and research administrator

Jonathan Liebenau

doi:10.1017/S0025727300050274

Abstract

An abstract is not available for this content so a preview has been provided. As you have access to this content, a full PDF is available via the ‘Save PDF’ action button.

Image of the first page of this content. For PDF version, please use the ‘Save PDF’ preceeding this image.'

Crossref Citations

This article has been cited by the following publications. This list is generated based on data provided by Crossref.

Parish, Lawrence Charles Crissey, John Thome and Parish, Jennifer L. 1991. Bibliography of Secondary Sources on the History of Dermatology. International Journal of Dermatology, Vol. 30, Issue. 7, p. 509.

Luttenberger, Franz 1992. Arrhenius vs. Ehrlich on immunochemistry: Decisions about scientific progress in the context of the Nobel prize. Theoretical Medicine, Vol. 13, Issue. 2, p. 137.

Vernon, Keith 1994. Microbes at work. Micro-organisms, the D.S.I.R. and industry in Britain, 1900–1936. Annals of Science, Vol. 51, Issue. 6, p. 593.

Löwy, Ilana 1994. On hybridizations, networks and new disciplines: The Pasteur Institute and the development of microbiology in France. Studies in History and Philosophy of Science Part A, Vol. 25, Issue. 5, p. 655.

Marsch, Ulrich 1994. Strategies for success: Research organization in German chemical companies and IG Farben until 1936*. History and Technology, Vol. 12, Issue. 1, p. 23.

Kasten, Frederick H. 1996. Paul Ehrlich: Pathfinder in Cell Biology 1. Chronicle of His Life and Accomplishments in Immunology, Cancer Research, and Chemotherapy1: Paul Ehrlich's Recipe for Success: “Patience, Ability, Money and Luck”. Biotechnic & Histochemistry, Vol. 71, Issue. 1, p. 2.

Cassier, Maurice 2002. Les logiques de l'innovation. p. 155.

Mahmoudian, Masoud and Rahimi-Moghaddam, Parvaneh 2008. The life and work of Abu ul-Ala Shirazi (d. 1001): a Persian pioneer in the treatment of malaria, in the style of Rhazes (865–925). Journal of Medical Biography, Vol. 16, Issue. 4, p. 186.

Rommetveit, Kjetil 2008. Towards a hermeneutic of technomedical objects. Theoretical Medicine and Bioethics, Vol. 29, Issue. 2, p. 103.

Hüntelmann, Axel C. 2008. The Dynamics ofWertbestimmung. Science in Context, Vol. 21, Issue. 2, p. 229.

Gradmann, Christoph 2008. Locating Therapeutic Vaccines in Nineteenth-Century History. Science in Context, Vol. 21, Issue. 2, p. 145.

Prüll, Cay-Rüdiger 2010. Evaluating and Standardizing Therapeutic Agents, 1890–1950. p. 13.

Grabenstein, John D. 2010. Vaccines: A Biography. p. 105.

Tilles, Gérard 2011. Dermatologie des XIXe et XXe siècles Mutations et controverses. p. 183.

Liebenau, Jonathan and Gundlach, Justin 2013. Modernizing the Business of Health: Pharmaceuticals in Britain, in comparison with Germany and the United States, 1890–1940: Table 1. Industrial and Corporate Change, Vol. 22, Issue. 3, p. 807.

Buchwalow, Igor Boecker, Werner and Tiemann, Markus 2015. The contribution of Paul Ehrlich to histochemistry: a tribute on the occasion of the centenary of his death. Virchows Archiv, Vol. 466, Issue. 1, p. 111.

2015. L'invention d'un médicament. p. 237.

Andrade, E.L. Bento, A.F. Cavalli, J. Oliveira, S.K. Freitas, C.S. Marcon, R. Schwanke, R.C. Siqueira, J.M. and Calixto, J.B. 2016. Non-clinical studies required for new drug development - Part I: early in silico and in vitro studies, new target discovery and validation, proof of principles and robustness of animal studies. Brazilian Journal of Medical and Biological Research, Vol. 49, Issue. 11,

Sawchik, J. Hamdani, J. and Vanhaeverbeek, M. 2018. Randomized clinical trials and observational studies in the assessment of drug safety. Revue d'Épidémiologie et de Santé Publique, Vol. 66, Issue. 3, p. 217.

Campbell, J. N. and Rooney, Steven M. 2018. A Time-Release History of the Opioid Epidemic. p. 59.

Download full list

Article contents

Paul Ehrlich as a commercial scientist and research administrator

Abstract

Save article to Kindle

Save article to Dropbox

Save article to Google Drive

Reply to: Submit a response

Your details

You have entered the maximum number of contributors

Conflicting interests